Latest filing published 19 Mar 2026 for Biohaven Ltd.. Read the official filing
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
No signal scores available.
Filings by Kishan Mehta span 2 companies, the busiest being Biohaven Ltd. and Biohaven Pharmaceutical Holding Co Ltd. Over a trading history stretching from 10 January 2022 to 17 March 2026, the count stands at 4 filings.
None of the filings is a plain purchase or sale on the open market; they cover grants, option exercises and other movements. Compensation-driven entries like these are tracked, but they say little about how insiders judge the share price.
The record was last updated on 19 March 2026 with a transaction in Biohaven Ltd. The median gap between a trade and its publication by SEC (Form 4) is 2 days. For comparison, the SEC allows two business days to file a Form 4. Source: insider filings from SEC (Form 4). Past trades are no guide to future returns.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
4 of 4 declarations